Cargando…
Unwavering Pathobiology of Volumetric Muscle Loss Injury
Volumetric muscle loss (VML) resulting from extremity trauma presents chronic and persistent functional deficits which ultimately manifest disability. Acellular biological scaffolds, or decellularized extracellular matrices (ECMs), embody an ideal treatment platform due to their current clinical use...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640632/ https://www.ncbi.nlm.nih.gov/pubmed/29030619 http://dx.doi.org/10.1038/s41598-017-13306-2 |
_version_ | 1783271065114378240 |
---|---|
author | Greising, Sarah M. Rivera, Jessica C. Goldman, Stephen M. Watts, Alain Aguilar, Carlos A. Corona, Benjamin T. |
author_facet | Greising, Sarah M. Rivera, Jessica C. Goldman, Stephen M. Watts, Alain Aguilar, Carlos A. Corona, Benjamin T. |
author_sort | Greising, Sarah M. |
collection | PubMed |
description | Volumetric muscle loss (VML) resulting from extremity trauma presents chronic and persistent functional deficits which ultimately manifest disability. Acellular biological scaffolds, or decellularized extracellular matrices (ECMs), embody an ideal treatment platform due to their current clinical use for soft tissue repair, off-the-shelf availability, and zero autogenous donor tissue burden. ECMs have been reported to promote functional skeletal muscle tissue remodeling in small and large animal models of VML injury, and this conclusion was reached in a recent clinical trial that enrolled 13 patients. However, numerous other pre-clinical reports have not observed ECM-mediated skeletal muscle regeneration. The current study was designed to reconcile these discrepancies. The capacity of ECMs to orchestrate functional muscle tissue remodeling was interrogated in a porcine VML injury model using unbiased assessments of muscle tissue regeneration and functional recovery. Here, we show that VML injury incites an overwhelming inflammatory and fibrotic response that leads to expansive fibrous tissue deposition and chronic functional deficits, which ECM repair does not augment. |
format | Online Article Text |
id | pubmed-5640632 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-56406322017-10-18 Unwavering Pathobiology of Volumetric Muscle Loss Injury Greising, Sarah M. Rivera, Jessica C. Goldman, Stephen M. Watts, Alain Aguilar, Carlos A. Corona, Benjamin T. Sci Rep Article Volumetric muscle loss (VML) resulting from extremity trauma presents chronic and persistent functional deficits which ultimately manifest disability. Acellular biological scaffolds, or decellularized extracellular matrices (ECMs), embody an ideal treatment platform due to their current clinical use for soft tissue repair, off-the-shelf availability, and zero autogenous donor tissue burden. ECMs have been reported to promote functional skeletal muscle tissue remodeling in small and large animal models of VML injury, and this conclusion was reached in a recent clinical trial that enrolled 13 patients. However, numerous other pre-clinical reports have not observed ECM-mediated skeletal muscle regeneration. The current study was designed to reconcile these discrepancies. The capacity of ECMs to orchestrate functional muscle tissue remodeling was interrogated in a porcine VML injury model using unbiased assessments of muscle tissue regeneration and functional recovery. Here, we show that VML injury incites an overwhelming inflammatory and fibrotic response that leads to expansive fibrous tissue deposition and chronic functional deficits, which ECM repair does not augment. Nature Publishing Group UK 2017-10-13 /pmc/articles/PMC5640632/ /pubmed/29030619 http://dx.doi.org/10.1038/s41598-017-13306-2 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Greising, Sarah M. Rivera, Jessica C. Goldman, Stephen M. Watts, Alain Aguilar, Carlos A. Corona, Benjamin T. Unwavering Pathobiology of Volumetric Muscle Loss Injury |
title | Unwavering Pathobiology of Volumetric Muscle Loss Injury |
title_full | Unwavering Pathobiology of Volumetric Muscle Loss Injury |
title_fullStr | Unwavering Pathobiology of Volumetric Muscle Loss Injury |
title_full_unstemmed | Unwavering Pathobiology of Volumetric Muscle Loss Injury |
title_short | Unwavering Pathobiology of Volumetric Muscle Loss Injury |
title_sort | unwavering pathobiology of volumetric muscle loss injury |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640632/ https://www.ncbi.nlm.nih.gov/pubmed/29030619 http://dx.doi.org/10.1038/s41598-017-13306-2 |
work_keys_str_mv | AT greisingsarahm unwaveringpathobiologyofvolumetricmusclelossinjury AT riverajessicac unwaveringpathobiologyofvolumetricmusclelossinjury AT goldmanstephenm unwaveringpathobiologyofvolumetricmusclelossinjury AT wattsalain unwaveringpathobiologyofvolumetricmusclelossinjury AT aguilarcarlosa unwaveringpathobiologyofvolumetricmusclelossinjury AT coronabenjamint unwaveringpathobiologyofvolumetricmusclelossinjury |